The goal of carotid disease management is prevention of stroke. Many randomized prospective trials of carotid disease management provide level-1 evidence to guide decision making to optimize stroke prevention in patients with carotid disease. Other patients present with clinical scenarios that fall outside the eligibility criteria for these clinical trials, and in these patients, clinical decisions must be based on the best available information on the natural history of each patient’s carotid disease and on the clinician’s assessment of the risks and benefits of intervention. In this monograph, the author reviews the current clinical data relating to carotid revascularization for asymptomatic carotid disease, for carotid disease with transient ischemic attack or minor stroke, and for carotid disease with acute stroke or stroke in evolution. Relevant clinical trials of carotid endarterectomy and carotid stenting are reviewed in detail. In addition, relevant natural history and risk—benefit data are reviewed to guide clinical decision making in patients whose clinical presentations fall outside the scope of the available clinical trials. The goal of this monograph is to provide the clinician with an evidence basis for clinical decision making in patients with commonly encountered carotid disease—related presentations.
Hobson RW, Weiss DG, Fields WS, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med. 1993;328:221-227.
2.
Executive Committee for Asymptomatic Carotid Atherosclerosis Study.Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-1428.
3.
ACST Collaborators Group: The International Asymptomatic Carotid Surgery Trial (ACST). Lancet. 2004;363:1491-1502.
4.
Chambers BR , Norris JWOutcome in patients with asymptomatic neck bruits. N Engl J Med. 1986;315:860-865.
5.
O’Holleran LW, Kennelly MM, McClurken M., Johnson JMNatural history of asymptomatic carotid plaque . Am J Surg. 1987;154:659-662.
6.
Nicolaides AN , Kakkos SK, Griffin M., et al. Effect of image normalization on carotid plaque classification and the risk of ipsilateral hemispheric ischemic events: results from the asymptomatic carotid stenosis and risk of stroke study. Vascular. 2005 ;13:211-221.
7.
Nicolaides ANAsymptomatic carotid stenosis and risk of stroke: identification of a high-risk group. Int Angiol. 1995;14:21-28.
8.
Roederer GO, Langlois YE, Jager KA, et al. The natural history of carotid arterial disease in asymptomatic patients with cervical bruits. Stroke. 1984 ;15:605-613.
9.
Takaya N., Yuan C., Chu B., et al. Association between carotid plaque characteristics and subsequent cerebrovascular events. Stroke. 2006;37:818-823.
10.
Alvarez B., Ruiz C., Chacon P., Alvarez-Sabin J., Matas M.Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. J Vasc Surg. 2004 ;40:469-475.
11.
Garcia BA, Ruiz C., Chacon P., Sabin JA, Matas M.High sensitivity C-reactive protein in high grade carotid stenosis: risk marker for unstable plaque. J Vasc Surg. 2003;38:1018-1024.
12.
Arthurs ZM, Andersen C., Starnes BW, Sohn VY, Mullenix PS, Perry J.A prospective evaluation of C-reactive protein in the progression of carotid artery stenosis. J Vasc Surg. 2008 ;47:744-751.
13.
Hobson RW, Mackey WC, Ascher E., et al. Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg. 2008;48:480-486.
14.
Liapis CD, Bell PF, Mikhaidilis D., et al. ESVS guidelines: invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg.2009 ;37(suppl 4):1-19.
15.
Brott TG, Hobson RW, Howard G., et al. Stenting versus endarterectomy for treatment of carotid artery stenosis. N Engl J Med. 2010;363:11-23.
16.
North American Symptomatic Carotid Endarterectomy Trial Collaborators.Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
17.
Barnett HJM , Taylor DW, Eliaziw M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis . N Engl J Med. 1998;339:1415-1425.
18.
European Carotid Surgery Trialists’ Collaborative Group.MRC European Carotid Surgery Trial: interim results for patients with severe (70-99%) or mild (0-29%) carotid stenosis. Lancet. 1991;337:1235-1243.
19.
European Carotid Surgery Trialists’ Collaborative Group.Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998 ; 351:1379-1387.
20.
Rothwell PM , Eliaziw M., Gutnikov SA, et al. Carotid Endarterectomy Trialists Collaboration: endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet . 2004;363:915-924.
21.
Collins R., Armitage J., Parish S., Sleight P., Peto R.; Heart Protection StudyCollaborative Group.Effects of cholesterol-lowering with Simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high risk conditions. Lancet. 2004 ;363:757-767.
22.
Crouse JR, Byington RP, Hoen HM, Furberg CDReductase inhibitor monotherapy and stroke prevention. Arch Int Med. 1997;157:1305-1310.
23.
Mas JL, Chatellier G., Beyssen B., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006 ;355:1660-1671.
24.
Ringleb PA, Allenberg J., Bruckmann H., et al. 30 Day results from the SPACE trial of stent protected angioplasty versus carotid endarterectomy in symptomatic patients, a non-inferiority analysis . Lancet. 2006;368:1239-1247.
25.
Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid artery stenting versus endarterectomy in high risk patients. N Engl J Med. 2004;351:1493-1501.
26.
Gasparis AP , Ricotta L., Cuadra SA, et al. High risk carotid endarterectomy: fact or fiction? J Vasc Surg. 2003; 37:40-46.
27.
Wylie, EJ, Hein MF, Adams JEIntracranial hemorrhage following surgical revascularization for treatment of acute strokes. J Neurosurg. 1964;21:212-218.
28.
Piotrowski J., Bernhard V., Rubin J., et al. Timing of carotid endarterectomy after acute stroke. J Vasc Surg. 1990;11:45-52.
29.
Whittemore AD, Mannick JASurgical treatment of carotid disease in patients with neurologic deficits. J Vasc Surg. 1987 ;5:910-916.
30.
Gasecki AP, Ferguson GG, Eliaziw M., et al. Early endarterectomy for severe carotid stenosis after a nondisabling stroke: results from the North American Symptomatic Carotid Endarterectomy Trial. J Vasc Surg. 1994; 20:288-295.
31.
Roddy SP, Mackey WCAcute stroke. In: Cronenwett JL, Rutherford RB, eds. Clinical Decision Making in Vascular Surgery. Philadelphia, PA: W B Saunders;2001:50-53.
